药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Insulin glulisine
Glasdegib
Glasdegib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.
Insulin glulisine
Baricitinib
Baricitinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.
Insulin glulisine
Olaparib
Olaparib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.
Insulin glulisine
Palbociclib
Palbociclib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.
Insulin glulisine
Cannabidiol
Cannabidiol may decrease the excretion rate of Dolutegravir which could result in a higher serum level.
Insulin glulisine
Isavuconazole
The serum concentration of Dolutegravir can be increased when it is combined with Isavuconazole.
Insulin glulisine
Pitolisant
The serum concentration of Dolutegravir can be increased when it is combined with Pitolisant.
Insulin glulisine
Apalutamide
The serum concentration of Dolutegravir can be decreased when it is combined with Apalutamide.
Insulin glulisine
Tipiracil
The excretion of Tipiracil can be decreased when combined with Dolutegravir.
Insulin glulisine
Lumacaftor
The serum concentration of Dolutegravir can be decreased when it is combined with Lumacaftor.
Insulin glulisine
Ferric maltol
Ferric maltol can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Ferric oxyhydroxide
Ferric oxyhydroxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Tetraferric tricitrate decahydrate
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Ferrous fumarate
Ferrous fumarate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Ferrous succinate
Ferrous succinate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Ferrous gluconate
Ferrous gluconate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Ferric cation
Ferric cation can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Ferric hydroxide
Ferric hydroxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Sodium feredetate
Sodium feredetate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Ferrous sulfate anhydrous
Ferrous sulfate anhydrous can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.